Prosthetic Joint Infection clinical trials

Explore recruiting prosthetic joint infection clinical trials.

Recruiting prosthetic joint infection studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prosthetic Joint Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Rifampicin Combination Therapy versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute

France

Phase II and Phase III (Integrated) EU CTIS Study details

RIFAMAB : Rifabutin versus rifampicin for treatment of staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy): a multicenter randomized, open-label, non-inferiority trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

PhagoDAIR I : A Pilot, Multicenter, Randomized, Non Comparative, Double-Blind Study of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus Treated with DAIR and Antibiotic Therapy.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Prosthetic Joint Infection trials by city

Prosthetic Joint Infection clinical trials

Recruiting prosthetic joint infection studies right now

Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

Reduction of Bacterial Seeding in Total Shoulder Arthroplasty

The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee

CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee

IP-coated Revision Hip Implants

SHort Interval Full Two-stage Implant Exchange

Methylene Blue in Total Knee Arthroplasty (TKA)

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection

Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR

Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection

The Use of CCK vs PS in Revision TKAs

Also recruiting in Europe

Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis

Rifampicin Combination Therapy versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection

Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial

Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute

RIFAMAB : Rifabutin versus rifampicin for treatment of staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy): a multicenter randomized, open-label, non-inferiority trial

PhagoDAIR I : A Pilot, Multicenter, Randomized, Non Comparative, Double-Blind Study of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus Treated with DAIR and Antibiotic Therapy.

Prosthetic Joint Infection trials by city

Other conditions